Financials

Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1684
CLDX
Celldex Therapeutics, Inc. - Common Stock
40.30 USD-0.40%-1.52%+13.27%+47.94%3.16 B USD
1688
NAMS
NewAmsterdam Pharma Company N.V. - Ordinary Shares
26.38 USD-1.53%-5.01%-6.62%-27.27%3.15 B USD
1697
TARS
Tarsus Pharmaceuticals, Inc. - Common Stock
71.29 USD-0.88%-1.75%+21.32%+7.92%3.13 B USD
1724
BEAM
Beam Therapeutics Inc. - Common Stock
29.36 USD-3.67%-1.48%+12.10%+74.04%3.03 B USD

Noticias